Marché des compteurs d'immuno-essais gamma en Asie-Pacifique, par type de produit (automatisé, manuel/semi-automatisé), puits (puits multiples, puits unique), application (immuno-essais radio, dosages de médecine nucléaire, autres), état pathologique ( biomarqueur du cancer , maladies infectieuses, surveillance thérapeutique des médicaments, hormones endocriniennes, allergie, dépistage néonatal, marqueurs cardiaques, maladie auto-immune, autres), mode d'achat (achat direct, achat de location), utilisateur final (laboratoire, hôpitaux, instituts de recherche et universitaires, sociétés pharmaceutiques et biotechnologiques, banques du sang, autres), canal de distribution (appel d'offres direct, distributeurs tiers), pays (Japon, Chine, Australie, Inde, Corée du Sud, Singapour, Indonésie, Thaïlande, Malaisie, Philippines, Vietnam, reste de l'Asie-Pacifique) Tendances et prévisions de l'industrie jusqu'en 2028.
Analyse et perspectives du marché : Marché des compteurs d'immuno-essais gamma en Asie-Pacifique
Le marché des compteurs d’immuno-essais gamma en Asie-Pacifique devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 6,9 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 23,45 millions USD d’ici 2028. La prévalence croissante des maladies chroniques et l’adoption croissante de la médecine nucléaire sont les principaux moteurs qui ont propulsé la demande du marché au cours de la période de prévision.
Un immuno-essai est un test biochimique qui mesure la présence ou la concentration d'une macromolécule ou d'une petite molécule dans une solution grâce à l'utilisation d'un anticorps ou d'un antigène. Le test biochimique est effectué à l'aide d'un appareil appelé « compteur gamma ». Un compteur gamma est un instrument permettant de mesurer le rayonnement gamma émis par un radionucléide. Contrairement aux appareils de mesure, les compteurs gamma sont conçus pour mesurer de petits échantillons de matières radioactives, généralement avec une mesure et un déplacement automatisés de plusieurs échantillons. L'augmentation des dépenses en recherche et développement, l'augmentation des dépenses de santé et la sensibilisation croissante des patients au traitement des maladies chroniques devraient offrir une opportunité de croissance lucrative pour le marché. Cependant, le coût élevé des compteurs gamma et le risque de rayonnement gamma sont les facteurs qui devraient freiner la croissance du marché au cours de la période de prévision.
Le rapport sur le marché des compteurs d'immuno-essais gamma fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et localisé, analyse les opportunités en termes de poches de revenus émergentes, de changements dans la réglementation du marché, d'approbations de produits, de décisions stratégiques, de lancements de produits, d'expansions géographiques et d'innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché des compteurs gamma d'immuno-essais en Asie-Pacifique
Le marché des compteurs gamma d'immuno-essais est segmenté en fonction du type de produit, du puits, de l'application, de l'état de la maladie, du mode d'achat, de l'utilisateur final et du canal de distribution. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.
- Sur la base du type de produit, le marché des compteurs d'immuno-essais gamma de la région Asie-Pacifique est segmenté en automatisé, manuel/semi-automatisé. En 2021, le segment automatisé devrait dominer le marché car il offre un retour sur investissement plus rapide, une production accrue et une empreinte environnementale plus faible.
- Sur la base des puits, le marché des compteurs d'immuno-essais gamma de la région Asie-Pacifique est segmenté en multipuits et monopuits. En 2021, le segment multipuits devrait dominer le marché en raison de mesures précises et de la capacité à produire des niveaux de spectre plus élevés en peu de temps.
- En fonction des applications, le marché des compteurs d'immuno-essais gamma de la région Asie-Pacifique est segmenté en radio-immuno-essais, en essais de médecine nucléaire et autres. En 2021, les radio-immuno-essais devraient dominer le marché en raison de réactions immunitaires très spécifiques et d'une sensibilité plus élevée des réactions immunitaires.
- Sur la base de l'état de la maladie, le marché des compteurs d'immuno-essais gamma de la région Asie-Pacifique est segmenté en biomarqueurs du cancer, maladies infectieuses, surveillance thérapeutique des médicaments , hormones endocriniennes, allergies, dépistage néonatal, marqueurs cardiaques, maladies auto-immunes, etc. En 2021, le segment des biomarqueurs du cancer devrait dominer le marché en raison des avancées technologiques et de l'augmentation des investissements du gouvernement et du secteur privé dans la R&D pour le diagnostic du cancer.
- Sur la base du mode d'achat, le marché des compteurs d'immuno-essais gamma de la région Asie-Pacifique est segmenté en achat direct et achat-location. En 2021, le segment de l'achat direct devrait dominer le marché en raison de la possibilité de déduction des amortissements et d'un prix ou d'un coût total réduit
- Sur la base de l'utilisateur final, le marché des compteurs d'immuno-essais gamma de la région Asie-Pacifique est segmenté en laboratoires, hôpitaux, instituts de recherche et universitaires, sociétés pharmaceutiques et biotechnologiques, banques de sang, etc. En 2021, le segment des laboratoires devrait dominer le marché en raison de sa précision et de son exactitude.
- Sur la base du canal de distribution, le marché des compteurs d'immuno-essais gamma de la région Asie-Pacifique est segmenté en ventes directes et distributeurs tiers. En 2021, le segment des appels d'offres directs devrait dominer le marché car il augmente l'efficacité et réduit le temps de remplissage.
Analyse du marché des compteurs d'immuno-essais gamma au niveau des pays
Le marché des compteurs d’immunoessais gamma est analysé et des informations sur la taille du marché sont fournies sur la base du type de produit, du puits, de l’application, de l’état de la maladie, du mode d’achat, de l’utilisateur final et du canal de distribution comme référencé ci-dessus.
The countries covered in the laxative market report are the Japan, China, India, Australia, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific.
Out-right purchase segment in Japan is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 due to possibility of depreciation deduction, and tax incentives.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Product approvals and novelty in diagnosis procedures are boosting the market growth of immunoassay-gamma counters
Immunoassay gamma counters market also provides you with detailed market analysis for every country growth in immunoassay-gamma counters industry with drugs sales, impact of advancement, technology and changes in regulatory scenarios with their support for the immunoassay-gamma counters. The data is available for historic period 2011 to 2019.
Competitive Landscape and Immunoassay-Gamma Counters Market Share Analysis
Immunoassay gamma counters market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to immunoassay-gamma counters market.
The major companies operating in the Asia-Pacific immunoassay-gamma counters market are Hidex Oy, Perkin Elmer Inc, Berthold Technologies GmbH & Co. KG, ENERSYS Co. Ltd, Shinjin Medics Inc, LabLogic Systems Ltd, among others.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the immunoassay-gamma counters market.
For instance,
- In July 2021, PerkinElmer Inc. announced that the company is further looking to expand their footprints in India by relying on innovative products. The new products will be launched in various streams such as science, pharma, and food testing. This has helped the company to expand its global presence
- En novembre 2020, Berthold Technologies GmbH & Co.KG a annoncé que le confinement partiel avait été ordonné pour réduire le taux d'infection. Cependant, l'entreprise a assuré aux clients que la livraison serait fiable car elle maintenait la production pendant cette période, en suivant les directives appropriées du gouvernement. Cela aide l'entreprise à maintenir la demande et à générer des revenus pendant la pandémie
La collaboration, le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché améliorent le marché de l'entreprise sur le marché des compteurs d'immuno-essais gamma, ce qui offre également l'avantage à l'organisation d'améliorer son offre de compteurs d'immuno-essais gamma.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTES FIVE FORCES
5 REGULATORY GUIDELINES FOR IMMUNOASSAY-GAMMA COUNTERS
5.1 U.S. REGULATORY GUIDELINES FOR IMMUNOASSAYS-GAMMA COUNTERS
5.2 EUROPE REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
5.3 JAPAN REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
5.4 CHINA REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN PREVALENCE OF CHRONIC DISEASES
6.1.2 PRODUCT APPROVAL
6.1.3 INCREASE IN ADOPTION OF NUCLEAR MEDICINE
6.1.4 NOVELTY IN DIAGNOSIS PROCEDURES
6.1.5 UPGRADING GAMMA TECHNOLOGY
6.2 RESTRAINTS
6.2.1 HIGH COST OF GAMMA COUNTER
6.2.2 RISK OF GAMMA RADIATION
6.2.3 STRINGENT REGULATION OF CLINICAL USE OF GAMMA COUNTER
6.2.4 PRODUCT RECALL
6.3 OPPORTUNITIES
6.3.1 GROWING RESEARCH AND DEVELOPMENT EXPENDITURE
6.3.2 INCREASE IN HEALTHCARE EXPENDITURE
6.3.3 RISE IN PATIENTS AWARENESS TOWARDS CHRONIC DISEASE TREATMENT
6.4 CHALLENGES
6.4.1 CHALLENGES IN USING GAMMA COUNTER
6.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
7 IMPACT OF COVID-19 ON ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET
7.1 IMPACT ON THE PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY
7.4 STRATEGIC INITIATIVES BY MANUFACTURERS
7.5 CONCLUSION
8 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 AUTOMATED
8.2.1 RADIOIMMUNOASSAYS
8.2.1.1 RIA
8.2.1.2 IRMA
8.2.2 NUCLEAR MEDICINE ASSAYS
8.2.2.1 GFR (Glomerular FILTRATION RATE)
8.2.2.2 Gamma glutamyl transferase (ggt)
8.2.2.3 red cell mass and plasma volume test
8.2.2.4 THE SCHILLING TEST
8.2.2.5 others
8.2.3 OTHERS
8.3 MANUAL/SEMI-AUTOMATED
8.3.1 RADIOIMMUNOASSAYS
8.3.1.1 RIA
8.3.1.2 IRMA
8.3.2 NUCLEAR MEDICINE ASSAYS
8.3.2.1 GFR (Glomerular FILTRATION RATE)
8.3.2.2 Gamma glutamyl transferase (ggt)
8.3.2.3 red cell mass and plasma volume test
8.3.2.4 THE SCHILLING TEST
8.3.2.5 others
8.3.3 OTHERS
9 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL
9.1 OVERVIEW
9.2 MULTI-WELL
9.3 SINGLE-WELL
10 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 RADIO IMMUNOASSAYS
10.2.1 RIA
10.2.2 IRMA
10.3 NUCLEAR MEDICINE ASSAY
10.3.1 GFR (GLOMERULAR FILTRATION RATE)
10.3.2 GAMMA-GLUTAMYL TRANSFERASE
10.3.3 RED CELL MASS AND PLASMA VOLUME TEST
10.3.4 THE SCHILLING TEST
10.3.5 OTHERS
10.4 OTHERS
11 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION
11.1 OVERVIEW
11.2 CANCER BIOMARKERS
11.2.1 CARBOHYDRATE ANTIGEN 125 (CA125)
11.2.2 CARBOHYDRATE ANTIGEN 19-9
11.2.3 CARCINO EMBRYONIC ANTIGEN
11.2.4 ALPHA-FETOPROTEIN
11.2.5 OTHERS
11.3 INFECTIOUS DISEASES
11.4 THERAPEUTIC DRUG MONITORING
11.5 ENDOCRINE HORMONES
11.6 ALLERGY
11.7 NEONATAL SCREENING
11.8 CARDIAC MARKERS
11.9 AUTOIMMUNE DISEASE
11.1 OTHERS
12 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE
12.1 OVERVIEW
12.2 OUTRIGHT PURCHASE
12.3 RENTAL PURCHASE
13 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 THIRD PARTY DISTRIBUTORS
14 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 LABORATORY
14.4 BLOOD BANKS
14.5 RESEARCH AND ACADEMIC INSTITUTES
14.6 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
14.7 OTHERS
15 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY GEOGRAPHY
15.1 ASIA-PACIFIC
15.1.1 JAPAN
15.1.2 SOUTH KOREA
15.1.3 CHINA
15.1.4 AUSTRALIA
15.1.5 INDIA
15.1.6 SINGAPORE
15.1.7 THAILAND
15.1.8 MALAYSIA
15.1.9 INDONESIA
15.1.10 PHILIPPINES
15.1.11 REST OF ASIA-PACIFIC
16 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 PERKINELMER INC.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 BRETHOLD TECHNOLOGIES GMBH & CO.KG
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENTS
18.3 LABLOGIC SYSTEMS LTD.
18.3.1 COMPANY SNAPSHOT
18.3.2 COMPANY SHARE ANALYSIS
18.3.3 PRODUCT PORTFOLIO
18.3.4 RECENT DEVELOPMENT
18.4 SHIN JIN MEDICS INC.
18.4.1 COMPANY SNAPSHOT
18.4.2 COMPANY SHARE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 HIDEX OY
18.5.1 COMPANY SNAPSHOT
18.5.2 COMPANY SHARE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENTS
18.6 LABORATORY TECHNOLOGIES. INC.
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.7 ENERSYS, CO.LTD.
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 MIRION TECHNOLOGIES (CAPINTEC),INC.
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
Liste des tableaux
TABLE 1 NUMBER OF PEOPLE WITH DIABETES (MILLION) AMONG AGES 20–79 YEARS
TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC
TABLE 3 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 6 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 7 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 8 ASIA-PACIFIC MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 9 ASIA-PACIFIC MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 10 ASIA-PACIFIC RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 11 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 13 ASIA-PACIFIC MULTI-WELL IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 14 ASIA-PACIFIC SINGLE-WELL IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 15 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 16 ASIA-PACIFIC RADIO IMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 17 ASIA-PACIFIC RADIO IMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 18 ASIA-PACIFIC NUCLEAR MEDICINE ASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 19 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 20 ASIA-PACIFIC OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 21 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 24 ASIA-PACIFIC INFECTIOUS DISEASES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 25 ASIA-PACIFIC THERAPEUTIC DRUG MONITORING IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 26 ASIA-PACIFIC ENDOCRINE HORMONES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC ALLERGY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 28 ASIA-PACIFIC NEONATAL SCREENING IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC CARDIAC MAKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 30 ASIA-PACIFIC AUTO IMMUNE DISEASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 32 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 33 ASIA-PACIFIC OUTRIGHT PURCHASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC RENTAL PURCHASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)
TABLE 35 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 36 ASIA-PACIFIC DIRECT TENDER IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 37 ASIA-PACIFIC THIRD PARTY DISTRIBUTORS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 38 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC HOSPITALS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC LABORATORY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC BLOOD BANKS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 20152028 (USD MILLION)
TABLE 42 ASIA-PACIFIC RESEARCH AND ACADEMIC INSTITUTES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 44 OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY COUNTRY, 2015-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 55 ASIA-PACIFIC RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 56 ASIA-PACIFIC NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 57 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 58 ASIA-PACIFIC CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 59 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 60 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 61 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 62 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 63 JAPAN AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 64 JAPAN RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 65 JAPAN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 66 JAPAN MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 67 JAPAN RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 68 JAPAN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 69 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 70 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 71 JAPAN RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 72 JAPAN NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 73 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 74 JAPAN CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 75 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 76 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 77 JAPAN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 78 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 79 SOUTH KOREA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 80 SOUTH KOREA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 81 SOUTH KOREA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 82 SOUTH KOREA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 83 SOUTH KOREA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 84 SOUTH KOREA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 85 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 86 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 87 SOUTH KOREA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 88 SOUTH KOREA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 89 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 90 SOUTH KOREA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 91 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 92 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 93 SOUTH KOREA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 94 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 95 CHINA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 96 CHINA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 97 CHINA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 98 CHINA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 99 CHINA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 100 CHINA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 101 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 102 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 103 CHINA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 104 CHINA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 105 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 106 CHINA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 107 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 108 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 109 CHINA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 110 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 111 AUSTRALIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 112 AUSTRALIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 113 AUSTRALIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 114 AUSTRALIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 115 AUSTRALIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 116 AUSTRALIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 117 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 118 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 119 AUSTRALIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 120 AUSTRALIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 121 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 122 AUSTRALIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 123 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 124 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 125 AUSTRALIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 126 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 127 INDIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 128 INDIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 129 INDIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 130 INDIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 131 INDIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 132 INDIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 133 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 134 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 135 INDIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 136 INDIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 137 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 138 INDIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 139 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 140 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 141 INDIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 142 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 143 SINGAPORE AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 144 SINGAPORE RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 145 SINGAPORE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 146 SINGAPORE MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 147 SINGAPORE RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 148 SINGAPORE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 149 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 150 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 151 SINGAPORE RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 152 SINGAPORE NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 153 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 154 SINGAPORE CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 155 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 156 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 157 SINGAPORE IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 158 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 159 THAILAND AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 160 THAILAND RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 161 THAILAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 162 THAILAND MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 163 THAILAND RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 164 THAILAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 165 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 166 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 167 THAILAND RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 168 THAILAND NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 169 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 170 THAILAND CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 171 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 172 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 173 THAILAND IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 174 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 175 MALAYSIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 176 MALAYSIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 177 MALAYSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 178 MALAYSIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 179 MALAYSIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 180 MALAYSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 181 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 182 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 183 MALAYSIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 184 MALAYSIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 185 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 186 MALAYSIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 187 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 188 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 189 MALAYSIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 190 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 191 INDONESIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 192 INDONESIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 193 INDONESIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 194 INDONESIA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 195 INDONESIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 196 INDONESIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 197 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 198 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 199 INDONESIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 200 INDONESIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 201 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 202 INDONESIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 203 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 204 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 205 INDONESIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 206 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 207 PHILIPPINES AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 208 PHILIPPINES RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 209 PHILIPPINES NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 210 PHILIPPINES MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 211 PHILIPPINES RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 212 PHILIPPINES NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
TABLE 213 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)
TABLE 214 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 215 PHILIPPINES RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 216 PHILIPPINES NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)
TABLE 217 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 218 PHILIPPINES CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)
TABLE 219 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)
TABLE 220 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)
TABLE 221 PHILIPPINES IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)
TABLE 222 REST OF ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)
Liste des figures
FIGURE 1 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: APPLICATION COVERAGE GRID
FIGURE 10 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION
FIGURE 12 INCREASE IN PREVALENCE OF CHRONIC DISEASES AND GROWING USE OF NUCLEAR MEDICINE IS EXPECTED TO DRIVE THE ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 AUTOMATED IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET
FIGURE 15 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS
FIGURE 16 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, 2020
FIGURE 17 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 18 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 19 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, 2020
FIGURE 21 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, 2021-2028 (USD MILLION)
FIGURE 22 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, CAGR (2021-2028)
FIGURE 23 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, 2020
FIGURE 25 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 26 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, CAGR (2021-2028)
FIGURE 27 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, 2020
FIGURE 29 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY DISEASE CONDITION, 2021-2028 (USD MILLION)
FIGURE 30 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, CAGR (2021-2028)
FIGURE 31 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, 2020
FIGURE 33 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, 2021-2028 (USD MILLION)
FIGURE 34 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, CAGR (2021-2028)
FIGURE 35 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, 2020
FIGURE 37 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 38 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 39 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, 2020
FIGURE 41 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, 2021-2028 (USD MILLION)
FIGURE 42 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, CAGR (2021-2028)
FIGURE 43 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: SNAPSHOT (2020)
FIGURE 45 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2020)
FIGURE 46 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2021 &2028)
FIGURE 47 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 49 ASIA-PACIFIC IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
